Pharma M&A Deals 2023 - Top Themes - Thematic Research
Summary
In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Summary
- This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector
Scope
- This report provides an overview of merger and acquisition activity globally in 2023 in Pharma Sector
- It identifies the themes driving most notable to deals announced in 2023 in the Pharma Sector
Reasons to Buy
Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.
Table of Contents
- Executive summary
- Review of pharma M&A market - 2023
- Top pharma M&A deals by sector - 2023
- Pharma M&A deals analysis by geography - 2023
- Top themes driving pharma M&A activity - 2023
- Appendix 1: Deal selection criteria
- Appendix 2: Top themes for 2023 in pharma
- Appendix 3: Thematic research methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bristol-Myers Squibb
- AbbVie
- Roche
- Orion Acquisition
- Bristol-Myers Squibb
- Cooper Consumer Health SAS
- IQuest Enterprises
- Ephios Luxembourg
- Biogen
- Bausch & Lomb
- Eli Lilly and Co
- Novartis
- Elliott Investment Management
- Patient Square Capital
- Veritas Capital
- Astellas Pharma
- Merck & Co
- Sartorius Stedim Biotech
- Pfizer
- Sanofi
- RayzeBio
- Karuna Therapeutics
- Cerevel Therapeutics
- Carmot Therapeutics
- ImmunoGen
- Telavant
- Olink Holding
- Mirati Therapeutics
- Viatris
- Synlab
- Reata Pharmaceuticals
- Novartis
- DICE Therapeutics
- Chinook Therapeutics
- Syneos
- IVERIC bio
- Prometheus Biosciences
- Polyplus-Transfection
- Seagen
- Provention Bio
